STOLFO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 5.352
EU - Europa 4.851
AS - Asia 1.014
AF - Africa 33
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 11.291
Nazione #
US - Stati Uniti d'America 5.323
IT - Italia 2.497
PL - Polonia 888
SE - Svezia 522
CN - Cina 407
HK - Hong Kong 374
DE - Germania 232
BG - Bulgaria 120
UA - Ucraina 116
IE - Irlanda 113
FI - Finlandia 86
TR - Turchia 53
GB - Regno Unito 49
RU - Federazione Russa 48
CH - Svizzera 39
IN - India 38
KR - Corea 36
BE - Belgio 34
VN - Vietnam 32
SG - Singapore 31
FR - Francia 25
CA - Canada 21
SN - Senegal 21
AT - Austria 16
BR - Brasile 15
NL - Olanda 15
RO - Romania 15
JP - Giappone 11
IR - Iran 9
GR - Grecia 8
MX - Messico 8
EU - Europa 7
EG - Egitto 6
AU - Australia 5
ID - Indonesia 5
CO - Colombia 4
DK - Danimarca 4
ES - Italia 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
AR - Argentina 3
BH - Bahrain 3
CL - Cile 3
NO - Norvegia 3
TZ - Tanzania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EE - Estonia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
SI - Slovenia 2
AL - Albania 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MW - Malawi 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
TG - Togo 1
Totale 11.291
Città #
Warsaw 887
Fairfield 779
Chandler 745
Ashburn 527
Woodbridge 464
Hong Kong 367
Houston 354
Seattle 322
Ann Arbor 319
Trieste 317
Wilmington 283
Cambridge 245
Milan 183
Rome 174
Princeton 163
Beijing 124
Jacksonville 123
Sofia 120
Naples 112
Dublin 101
Dearborn 62
Helsinki 56
Turin 55
Boardman 46
Izmir 46
Grafing 44
Florence 41
San Diego 41
Catania 33
Bremen 32
Seoul 32
Brussels 31
Padova 30
Dong Ket 28
Udine 28
Bari 26
Des Moines 25
Genoa 25
Mykolayiv 25
Palermo 25
Redmond 25
Redwood City 24
Washington 24
Bern 23
Jinan 23
Los Angeles 23
Dakar 21
Nanjing 20
Pune 20
Venezia 20
Falls Church 19
Verona 19
Bologna 18
Treviso 18
Venice 16
London 15
Kunming 14
Mestre 14
Shanghai 14
São Paulo 14
Vienna 14
Caserta 13
San Giovanni la Punta 13
Bergamo 12
Potenza 12
Shenyang 12
Toronto 12
Guangzhou 11
Norwalk 10
Brescia 9
Dongguan 9
Fremont 9
Hangzhou 9
Hebei 9
Latina 9
Pescara 9
Cagliari 8
Hefei 8
Leawood 8
Mumbai 8
Nanchang 8
Napoli 8
Phoenix 8
Tokyo 8
Trento 8
Cernusco sul Naviglio 7
Messina 7
Rimini 7
San Francisco 7
Sassari 7
Silea 7
Somerville 7
Buja 6
Enna 6
Gorizia 6
Menlo Park 6
Monfalcone 6
New York 6
Paese 6
Paola 6
Totale 8.165
Nome #
Linee guida sullo scompenso cardiaco a confronto: AHA 2022 versus ESC 2021 1.615
Cardiac fluid dynamics meets deformation imaging 359
Natural History of Dilated Cardiomyopathy in Children 334
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? 296
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 220
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 218
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 215
Treatment of Functional Mitral Regurgitation in Heart Failure 202
Left Ventricular Response to Cardiac Resynchronization Therapy: Insights From Hemodynamic Forces Computed by Speckle Tracking 197
Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy 196
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 184
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 182
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 178
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 177
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History 176
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 175
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 172
Evolving concepts in dilated cardiomyopathy 171
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 167
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 162
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 161
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases 158
Chapter 12: Prognostic Stratification and Importance of Follow-Up 158
Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature 156
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 147
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis 145
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 141
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 141
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 138
Coronary fistula of the left main artery draining in the right atrium and associated aorto-right atrial fistula 137
Chapter 3: Pathophysiology 136
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 133
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. 127
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 125
Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives 124
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 123
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathyhttps://arts.units.it/submit?resume=115962# 123
Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis 122
null 121
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 111
Impact of patient delay in a modern real world STEMI network 111
Dilated cardiomyopathy: Dilated cardiomyopathy: Clinical assessment and differential diagnosis 107
Value of Strain Imaging and Maximal Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy 107
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM 104
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 103
Calcific degeneration and rupture of the aortic valve and ascending aorta: From cardiac auscultation to multimodality imaging 101
ECG in dilated cardiomyopathy: Specific findings and long-term prognostic significance 100
Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry 98
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience 79
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 79
Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences 76
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy 76
Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 72
Prognostic significance of longitudinal strain in dilated cardiomyopathy with recovered ejection fraction 71
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 70
Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis 69
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 68
Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction 68
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 63
Impaired Right Ventricular Longitudinal Strain Without Pulmonary Hypertension in Patients Who Have Recovered From COVID-19 61
Effect of prehospital treatment in STEMI patients undergoing primary PCI 61
Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation 60
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 60
Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications 59
Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy 58
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 58
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 57
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 57
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 55
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 52
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 52
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure 48
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation 48
Advanced Heart Failure in Special Population: Cardiomyopathies and Myocarditis 47
The Arrhythmic Phenotype in Cardiomyopathy 46
Combining New Classes of Drugs for HFrEF: from Trials to Clinical Practice 45
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis 43
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring with Arrhythmic Risk in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy 42
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients 42
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy 41
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 40
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension 39
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 39
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 36
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator 34
Ventriculo-arterial uncoupling in acute heart failure: right heart is the matter 34
Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry. 34
The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child 32
Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathy 32
Left Atrial Reverse Remodeling in Dilated Cardiomyopathy 31
Using marginal structural joint models to estimate the effect of a time-varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy 29
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications 28
Heart failure with mid-range or mildly reduced ejection fraction 28
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 26
Use of sodium–glucose co-transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry 26
Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications 25
Dispositivi transcatetere per l’insufficienza cardiaca cronica: stato dell’arte 24
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 22
Assessment of Phasic Changes of Vascular Size by Automated Edge Tracking-State of the Art and Clinical Perspectives 21
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 21
Totale 11.638
Categoria #
all - tutte 30.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.535


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019375 0 0 0 0 0 0 0 0 0 74 187 114
2019/20202.043 76 101 115 280 143 214 230 173 263 154 137 157
2020/20211.875 144 185 156 303 171 144 165 128 98 177 84 120
2021/20221.352 67 82 67 75 85 125 63 43 137 142 136 330
2022/20233.242 188 291 294 420 270 415 151 291 314 150 287 171
2023/20242.092 204 161 169 220 213 266 390 303 63 103 0 0
Totale 11.905